🇺🇸 FDA
Company

Tempest

Tempest Therapeutics

TPST pharma USA

Quick answer

Tempest is a pharma company (TPST) headquartered in BRISBANE, CA, USA with 3 tracked pipeline programs.

Pipeline (3)

project

TPST-1120

Hepatocellular Carcinoma (HCC)

Phase 3 · small_molecule · active

1 trials project

Part 1 TPST-1120

Hepatocellular Carcinoma

Phase 1 · small_molecule · completed

1 trials project

TPST-1495 twice daily

Solid Tumor

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12215093

Bicyclic carboxamides and methods of use thereof

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11795156

Bicyclic carboxamides and methods of use thereof

Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11738009

Bicyclic compounds and their use in the treatment of cancer

Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11666557

Triazolone compounds and uses thereof

Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11638704

Bicyclic compounds and their use in the treatment of cancer

Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11472789

Bicyclic carboxamides and methods of use thereof

Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11066405

Bicyclic compounds and their use in the treatment of cancer

Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10968201

Bicyclic carboxamides and methods of use thereof

Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)